The GIP receptor component is believed to enhance metabolic and weight-loss effects, whilst glucagon receptor activation is hypothesised to increase energy expenditure and promote hepatic fat breakdown (lipolysis)
In children or adolescents with GH deficiency, height growth may be possible under medical treatment
In 59-y-old woman diagnosed with ER-positive lobular BC 2 y previously and treated with tamoxifen, ER-positive bone metastases were identified 1 y after initial diagnosis
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
PlexusDx offers seamless medication transitions
Understanding personal peptide pathway biology helps PlexusDx providers determine whether semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan or alternative compounds suit specific patients better